Skip to main content
Clinical Trials/NL-OMON52118
NL-OMON52118
Recruiting
Phase 4

The perioperative renal and metabolic outcomes after sodium-glucose cotransporter-2 inhibitor in cardiac surgery - an open-label phase IV randomized controlled trial - The MERCURI trial

Academisch Medisch Centrum0 sites80 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Academisch Medisch Centrum
Enrollment
80
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 18 to 90 years old (inclusive)
  • Undergoing elective cardiac surgery with cardio\-pulmonary bypass.
  • Providing informed consent

Exclusion Criteria

  • Current treatment with SGLT2 inhibitors.
  • Diabetes Mellitus Type 1
  • BMI\<25 for people with type 2 diabetes
  • Reduced renal function at baseline with eGFR\<30 ml/min.
  • Systolic blood pressure \< 100 mmHg at time of inclusion.
  • Emergency surgery, defined as in need of surgery for medical reasons \< 7
  • days, i.e. \*S1\-4\* according to the Amsterdam UMC classification.
  • Female of child\-bearing potential who is pregnant, breast\-feeding or intend
  • to become pregnant or is not using adequate contraceptive methods.
  • Known or suspected allergy to trial products or other drugs in the same

Outcomes

Primary Outcomes

Not specified

Similar Trials